FDA fails to approve cholesterol drug for kidney disease – Reuters
FDA fails to approve cholesterol drug for kidney diseaseReutersBy Anna Yukhananov | WASHINGTON (Reuters) – US health regulators amended the prescribing label for Merck & Co's cholesterol-lowering drug Vytorin to show it prevents heart problems …